Drugs / UIC202601
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07682948 | Jul → Sep 2026 overdue | hyperlipidemia, hypertensive disorder | Korea United Pharm. Inc. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UIC202601 | “UIC202601 1Tab/day for 7 days” NCT07682948 ↗ |